Topics
October 2016 | business Of Retinainnovations In Retina
Visual Function Biomarkers Needed for Dry AMD
Early detection may allow treatment, and possibly reversal. Part 2 of a two-part series.
Aron Shapiro
March 2016 | business Of Retinainnovations In Retina
Ocular Gene Therapy Trials Advance
Results of the first phase 3 trial were announced.
July 14, 2026
AMA Launches Interoperability Initiative to Advance Electronic Prior Authorization
Dompé Enrolls First Patient in Global Phase 3 Trial of Intranasal NGF Therapy for NAION
July 10, 2026
Opus Genetics Provides BEST1 Program Update
July 9, 2026
Biocon Announces Peer-Reviewed Data Supporting Yesafili in Diabetic Macular Edema
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
